Neos Therapeutics Receives CRL from FDA for Cotempla XR-ODT
November 10, 2015 at 18:00 PM EST
Neos Therapeutics, Inc. (Nasdaq: NEOS) today announced that the Company received a Complete Response Letter (CRL) from the U.S. Food and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.